000 01123 a2200313 4500
005 20250516115902.0
264 0 _c20130312
008 201303s 0 0 rus d
022 _a1997-7298
040 _aNLM
_beng
_cNLM
100 1 _aZavadenko, N N
245 0 0 _a[Attention deficit hyperactivity disorder with comorbid anxiety disorders: pharmacotherapy options].
_h[electronic resource]
260 _bZhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
_c2012
300 _a44-8 p.
_bdigital
500 _aPublication Type: Controlled Clinical Trial; English Abstract; Journal Article
650 0 4 _aAdolescent
650 0 4 _aAnti-Anxiety Agents
_xtherapeutic use
650 0 4 _aAnxiety Disorders
_xdrug therapy
650 0 4 _aAttention Deficit Disorder with Hyperactivity
_xdrug therapy
650 0 4 _aBiureas
_xtherapeutic use
650 0 4 _aChild
650 0 4 _aComorbidity
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aMale
650 0 4 _aTreatment Outcome
700 1 _aSolomasova, A A
773 0 _tZhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
_gvol. 112
_gno. 8
_gp. 44-8
999 _c22210822
_d22210822